BioSpace News Archive

The PPD clinical research business of Thermo Fisher Scientific has been named Clinical Research Company of the Year at the 2022 PharmaTimes Clinical Researcher of the Year International competition held recently in London.

SCYNEXIS, Inc. (NASDAQ: SCYX), today announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) of an additional indication for BREXAFEMME® (ibrexafungerp tablets) for the prevention of recurrent vulvovaginal candidiasis (RVVC).

Albireo Pharma, Inc. today announced the presentation of seven abstracts/posters at the European Association for the Study of the Liver (EASL) International Liver Congress™ 2022, being held June 22 – 26 in London.

CNS Pharmaceuticals, Inc. today announced that Sigmund Hsu , MD, member of the Company’s Scientific Advisory Board, presented an overview of its ongoing clinical trial evaluating Berubicin for the treatment of recurrent glioblastoma multiforme (GBM), at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting.

InVivo Therapeutics Announces Publication of 12- and 24-month Data for INSPIRE 1.0 Study in Peer-Reviewed Neurosurgery.

Altamira Therapeutics Ltd., a company dedicated to developing therapeutics that address important unmet medical needs, announced positive outcomes from testing Bentrio™ for protection in human rhinovirus infection.

The global pharma & healthcare market report points out the key trends and developments taking place in this business space in the ongoing COVID-19 times.

The industry analysis report is considered a valuable source of information about the global Hepatitis A Vaccine industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years.

The global physiotherapy equipment market size is expected to reach USD 24.91 Billion in 2028 and register a revenue CAGR of 5.2% over the forecast period, according to the latest report by Reports and Data.

The market for regenerative medicine is witnessing increased demand owing to the emergence of stem cell technology, increase in prevalence of chronic diseases, and advancements in surgical technologies.